<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="ko" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AHM</journal-id>
<journal-title-group>
<journal-title>Archives of Hand and Microsurgery</journal-title><abbrev-journal-title>Arch Hand Microsurg</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">2586-3290</issn>
<issn pub-type="epub">2586-3533</issn>
<publisher>
<publisher-name>Korean Society for Surgery of the Hand and Korean Society for Microsurgery</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.12790/ahm.20.0036</article-id>
<article-id pub-id-type="publisher-id">ahm-20-0036</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group subj-group-type="heading">
<subject>Microsurgery</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>건강한 아시아인들의 하지 림프관 주행 분석</article-title>
<trans-title-group>
<trans-title xml:lang="en">Lymphatic Vessels Mapping in the Lower Extremities of a Healthy Asian Population</trans-title>
</trans-title-group>
<alt-title alt-title-type="right-running-head">Lower Extremity Lymphatic Vessel Mapping</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Yun-Hwan</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>이</surname><given-names>유환</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-ahm-20-0036"/>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>Hyung-Kyu</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>김</surname><given-names>형규</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-ahm-20-0036"/>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>You</surname><given-names>Hi-Jin</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>유</surname><given-names>희진</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-ahm-20-0036"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3382-560X</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>Deok-Woo</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>김</surname><given-names>덕우</given-names></name>
</name-alternatives>
<xref ref-type="corresp" rid="c1-ahm-20-0036"/>
<xref ref-type="aff" rid="af1-ahm-20-0036"/>
</contrib>
<aff-alternatives id="af1-ahm-20-0036">
<aff xml:lang="en">Department of Plastic and Reconstructive Surgery, Korea University Ansan Hospital, Ansan, <country>Korea</country></aff>
<aff xml:lang="ko">고려대학교 안산병원 성형외과</aff>
</aff-alternatives>
</contrib-group>
<author-notes>
<corresp id="c1-ahm-20-0036">Corresponding author: Deok-Woo Kim Department of Plastic and Reconstructive Surgery, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea Tel: +82-31-412-4817 Fax: +82-31-457-5074 E-mail: <email>deokwookim@gmail.com</email></corresp>
<fn id="fn1-ahm-20-0036"><label>*</label><p>The abstract of this article was presented at the 7th Research &amp; Reconstructive Forum of the Korean Society of Plastic and Reconstructive Surgeons on April 21, 2017.</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2020</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>8</month>
<year>2020</year></pub-date>
<volume>25</volume>
<issue>3</issue>
<fpage>225</fpage>
<lpage>231</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>06</month>
<year>2020</year></date>
<date date-type="rev-recd">
<day>16</day>
<month>08</month>
<year>2020</year></date>
<date date-type="accepted">
<day>21</day>
<month>08</month>
<year>2020</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2020 Korean Society for Surgery of the Hand, Korean Society for Microsurgery, and Korean Society for Surgery of the Peripheral Nerve. All Rights reserved.</copyright-statement>
<copyright-year>2020</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<trans-abstract xml:lang="en">
<sec><title>Purpose</title>
<p>Intraoperative indocyanine green (ICG) lymphography is an effective tool to obtain real-time video images of functioning lymph vessels in edematous limbs. However, it is difficult to identify the course of lymph vessels in obese patients or patients with large dermal backflow. Without the image, surgeons have to rely on their experience when performing the skin incision to locate the lymphatic vessels. This study focused on elucidating lymphatic vessel flow patterns in healthy lower extremities in an Asian population to refer these findings for lymphedema treatment.</p></sec>
<sec><title>Methods</title>
<p>ICG fluorescence lymphography was performed by injecting 0.2 mL of ICG into the first web space of the foot. After 4 hours, fluorescence images of lymphatic vessels were obtained and the lymphatic vessels were marked. Three landmarks were designated; the medial malleolus, the medial patellar border, and the groin femoral artery. Straight lines connecting the points were drawn, and the distance between the connected lines and the marked lymphatic vessels was measured in eight points. </p></sec>
<sec><title>Results</title>
<p>Fifteen subjects with healthy lower extremities (15 right and 15 left) were included. The average course of the main lymph vessels passed 26.2&#x000b1;18.0 mm dorsally to the medial malleolus, 53.7&#x000b1;35.7 mm medially to the medial patellar border, and 25.5&#x000b1;19.2 mm medially to the three-quarters point of the upper landmark line.</p></sec>
<sec><title>Conclusion</title>
<p>The main functioning lymphatic vessel largely follows the great saphenous vein course, passes in front of the medial malleolus, runs over the posterior border of the medial epicondyle at the knee level, and travels anteriorly toward the inguinal lymph nodes.</p></sec>
</trans-abstract>
<kwd-group xml:lang="en">
<kwd>Lymphatic vessels</kwd>
<kwd>Lymphedema</kwd>
<kwd>Indocyanine green</kwd>
<kwd>Lymphography</kwd>
<kwd>Lower extremity</kwd>
</kwd-group>
</article-meta></front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Lymphedema is a disease due to the impairment of the lymphatic system. After suffering from the surgery, radiation therapy, infection, or trauma, patient&#x02019;s lymphatic system can be disrupted and lead progressive fluid retention and tissue swelling &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>&#x0005d;. Lately, lymphedema has been receiving more attention since it is a relatively common complication after the cancer treatment &#x0005b;<xref ref-type="bibr" rid="b2-ahm-20-0036">2</xref>&#x0005d;.</p>
<p>In lymphedema, structural changes in the lymphatic system precede clinical symptoms such as pain and change in appearance. The structural changes include abnormal lymphatic vessel dilation and twisting. Abnormal retention of contrast medium due to the change was reported in an imaging study as a result &#x0005b;<xref ref-type="bibr" rid="b3-ahm-20-0036">3</xref>&#x0005d;.</p>
<p>The conservative treatment of lymphedema includes compression garments, intensive bandaging, and massaging of the affected limb. For patients unresponsive to theses conservative therapies, surgical options are recommended. The options are circumferential liposuction, microsurgical lymphovenous shunts, and vascularized lymph node transfer &#x0005b;<xref ref-type="bibr" rid="b2-ahm-20-0036">2</xref>&#x0005d;. Among various surgical options lymphovenous anastomosis (LVA), which connects functioning lymphatics with small vein, has several advantages over other procedures. It can be performed under local anesthesia, is less invasive compared to other surgical techniques, and is effective in severe cases that are refractory to conservative therapy &#x0005b;<xref ref-type="bibr" rid="b4-ahm-20-0036">4</xref>-<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>&#x0005d;. To maximize the therapeutic effect of LVA, proper identification of the functioning lymphatic vessels and accurate incision for anastomosis within a limited operative time are important &#x0005b;<xref ref-type="bibr" rid="b4-ahm-20-0036">4</xref>-<xref ref-type="bibr" rid="b9-ahm-20-0036">9</xref>&#x0005d;. Lymphatic vessels undergo degeneration as lymphedema progresses, and it is difficult to find functioning lymph vessels in late-stage lymphedema. Surgical results of LVA are much favorable when functioning lymphatics are bypassed.</p>
<p>Indocyanine green (ICG) lymphography has lately been used to visualize the superficial lymphatic flow. ICG as a tracer for lymphography is a safe, effective, and minimally invasive method. Lymphatic vessel imaging allows surgeons to detect the precise location of the lymphatic vessels for microscopic surgery &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>,<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>,<xref ref-type="bibr" rid="b10-ahm-20-0036">10</xref>-<xref ref-type="bibr" rid="b13-ahm-20-0036">13</xref>&#x0005d;. Near-infrared camera is used to obtain real-time video images by tracing ICG dye movement &#x0005b;<xref ref-type="bibr" rid="b14-ahm-20-0036">14</xref>&#x0005d;. However, it is difficult to clearly identify the course of lymphatic vessels in obese patients and advanced lymphedema patients. As lymphedema progresses, dermal backflow makes it difficult to identify underlying lymphatic vessel course. Finding functioning lymphatics is not easy in patients with large dermal backflow &#x0005b;<xref ref-type="bibr" rid="b13-ahm-20-0036">13</xref>&#x0005d;. In such cases, surgeons might have to rely on their experienced intuition to locate skin the incision for large functioning lymphatic vessels &#x0005b;<xref ref-type="bibr" rid="b15-ahm-20-0036">15</xref>&#x0005d;.</p>
<p>A previous cadaver study revealed that large lymphatic vessels in the lower extremity travel close to the saphenous vein of the leg &#x0005b;<xref ref-type="bibr" rid="b16-ahm-20-0036">16</xref>&#x0005d;. The purpose of this study was to reveal the lymphatic vessel flow patterns in healthy lower extremities and to propose a reference for the lymphedema treatment.</p>
</sec>
<sec sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<p>This study protocol was approved by the Institutional Review Board of Korea University Ansan Hospital (No. AS17191). All volunteers provided written informed consent for participation in this study and the publication of their clinical images.</p>
<p>Between March 2016 and July 2017, we conducted a study using ICG lymphography. Fifteen volunteers (13 males, 2 females) were included in this study. Overall, 30 lower extremities were evaluated (bilateral limbs of 15 healthy volunteers). The age of the volunteers ranged between 24 and 46 years (mean, 29.0 years), and body mass index ranged between 20.4 and 27.1 kg/m<sup>2</sup> (mean, 23.2 kg/m<sup>2</sup>) (<xref rid="t1-ahm-20-0036" ref-type="table">Table 1</xref>).</p>
<p>Subcutaneous injection of 0.2 mL of ICG (Dongindang Pharm. Corp. Ltd., Siheung, Korea) was injected into the lower extremities at the first web space of the foot. After 4 hours, fluorescence images of the lymphatic vessels were obtained with a near-infrared camera (Moment K; IAN C&amp;S, Seoul, Korea), and the lymphatic vessels were marked (<xref rid="f1-ahm-20-0036" ref-type="fig">Figs. 1</xref>, <xref rid="f2-ahm-20-0036" ref-type="fig">2</xref>). Three landmarks were designated as (1) the medial malleolus, (2) the medial patellar border, and (3) the groin femoral artery. A straight line connecting the points was drawn, and the distance between the connected lines and the marked lymphatic vessels was measured in eight points (<xref rid="f3-ahm-20-0036" ref-type="fig">Fig. 3</xref>). If two or more lymph vessels were visible, the one with the largest diameter was chosen. If they appeared similar, the middle position was marked. All data were expressed as means and standard deviations (<xref rid="f4-ahm-20-0036" ref-type="fig">Fig. 4</xref>).</p>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<p>Fifteen subjects with healthy lower extremities (15 left and 15 right) were included in this study. From the distal end, the lymphatic vessels ran dorsally to the medial malleolus, passed posteriorly to the medial patellar border, and then coursed toward the inguinal lymph nodes (<xref rid="f2-ahm-20-0036" ref-type="fig">Fig. 2</xref>). The average course of the main lymph vessels passed 26.2&#x000b1;18.0 mm dorsally to the medial malleolus, 53.7&#x000b1;35.7 mm medially to the medial patellar border, and 25.5&#x000b1;19.2 mm medially to the three-quarters point of the upper landmark line (<xref rid="f4-ahm-20-0036" ref-type="fig">Fig. 4</xref>). Also, the ratio of the distance between the marked lymphatic vessels and landmarks to the circumference of each point was calculated and expressed in percentages (<xref rid="t2-ahm-20-0036" ref-type="table">Table 2</xref>, <xref rid="f4-ahm-20-0036" ref-type="fig">Fig. 4</xref>)</p>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>Lower extremity lymphedema is a stressful complication that can occur after the treatment of cancers, including breast cancers, gynecologic cancers, and urologic cancers &#x0005b;<xref ref-type="bibr" rid="b2-ahm-20-0036">2</xref>&#x0005d;. It frequently goes through a chronic course and is difficult to manage &#x0005b;<xref ref-type="bibr" rid="b17-ahm-20-0036">17</xref>&#x0005d;. Among several diagnostic tools for examining lymphedema, lymphoscintigraphy is widely used to detect abnormal lymphatic circulation and to localize the lymph nodes. However, its drawback is that it involves radiation exposure due to the use of a radioisotope and cannot visualize the precise course of the lymphatic vessels &#x0005b;<xref ref-type="bibr" rid="b13-ahm-20-0036">13</xref>&#x0005d;.</p>
<p>On the other hand, ICG lymphography uses a non-radioactive medium as a tracer. Since it does not carry a potential risk of radiation, ICG lymphography is widely used for evaluating lymphedema &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>,<xref ref-type="bibr" rid="b10-ahm-20-0036">10</xref>,<xref ref-type="bibr" rid="b12-ahm-20-0036">12</xref>,<xref ref-type="bibr" rid="b14-ahm-20-0036">14</xref>,<xref ref-type="bibr" rid="b18-ahm-20-0036">18</xref>-<xref ref-type="bibr" rid="b20-ahm-20-0036">20</xref>&#x0005d;. In 2007, Ogata et al. &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>&#x0005d; and Unno et al. &#x0005b;<xref ref-type="bibr" rid="b19-ahm-20-0036">19</xref>&#x0005d; reported the clinical application of ICG lymphography for the evaluation of lymphedema. Many authors investigated the clinical applications of ICG lymphography and obtained important information for lymphatic functional assessment and preoperative evaluation before microsurgical procedures &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>,<xref ref-type="bibr" rid="b10-ahm-20-0036">10</xref>,<xref ref-type="bibr" rid="b14-ahm-20-0036">14</xref>,<xref ref-type="bibr" rid="b19-ahm-20-0036">19</xref>&#x0005d;. The sensitivity of lymphedema detection using ICG lymphography was almost 100% in a rat model &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>&#x0005d;. With a proper injection of ICG into a subcutaneous layer devoid of blood vessels, the medium flows into the lymphatic system. Even though ICG is mistakenly injected into an artery or a vein, the blood flow washed the medium away in less than a minute. Therefore, accidentally injected medium did not affect the overall results &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>&#x0005d;.</p>
<p>Conservative and surgical treatment options for lymphedema are available. Most early-stage patients choose conservative treatment options using various compression therapies such as complex physical therapy, pneumatic pumps, and compressive garments &#x0005b;<xref ref-type="bibr" rid="b2-ahm-20-0036">2</xref>,<xref ref-type="bibr" rid="b21-ahm-20-0036">21</xref>&#x0005d;. After distressful conservative treatment fails, surgery is considered &#x0005b;<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>&#x0005d;. Various surgical methods are under practice including LVA, vascularized lymph node transfer, and suction-assisted lipectomy. Among these surgical treatments, LVA, which involves a bypass connecting the congested lymph vessels to the venous system, is the least invasive and most effective surgical treatment &#x0005b;<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>&#x0005d;.</p>
<p>Many surgeons employed ICG lymphography to visualize the superficial lymphatic flow. Since it allows real-time visualization of superficial (1 to 2 cm in depth) lymphatic vessels, the surgeons can identify the exact location of lymphatic vessels for LVA surgery &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>,<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>,<xref ref-type="bibr" rid="b10-ahm-20-0036">10</xref>-<xref ref-type="bibr" rid="b13-ahm-20-0036">13</xref>&#x0005d;. Acquired information allows surgeons to more accurately determine the skin incision site for LVA, to shorten the incision length, and to reduce the operative time &#x0005b;<xref ref-type="bibr" rid="b6-ahm-20-0036">6</xref>,<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>&#x0005d;.</p>
<p>However, ICG lymphography also has a limitation. It is hard to locate the lymphatic vessels deeper than 2 cm from the skin. Moreover, the technology is less accurate in advanced stage cases with the extension of dermal backflow (DB) patterns &#x0005b;<xref ref-type="bibr" rid="b11-ahm-20-0036">11</xref>-<xref ref-type="bibr" rid="b13-ahm-20-0036">13</xref>&#x0005d;. Unfortunately, large DB patterns frequently exist in patients with clinically early-stage lymphedema cases obscuring the lymphatic vessel visualization &#x0005b;<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>&#x0005d;. The limited image makes surgeons difficult to determine the incision site for LVA. To unburden such difficulty, we identified the approximate location of the lymphatic vessels in the lower extremities of healthy persons for use as a reference during surgery.</p>
<p>In 2016, Amore et al. &#x0005b;<xref ref-type="bibr" rid="b16-ahm-20-0036">16</xref>&#x0005d; reported that the course of superficial lymphatic vessels was often concentrated near the superficial venous system, especially the saphenous veins. According to that study, lymph vessels from the foot and the leg flowed into the lymph nodes of the inguinal region, which is consistent with our findings.</p>
<p>This study has some limitations. First, only 30 lower extremities are relatively small study groups. Second, the research group included only Asian volunteers. Third, more male volunteers than female volunteers were included due to some hesitation regarding body exposure. Fourth, the detection depth of the infrared camera system was limited and only the lymph vessels located in the dermis and subcutaneous fat layer were determined. The deep lymphatic system could not be assessed. The superficial lymphatics in patients with early-stage of lymphedema are usually maintained and might be more important for the operation than the deep lymphatic chains &#x0005b;<xref ref-type="bibr" rid="b14-ahm-20-0036">14</xref>&#x0005d;. Fifth, only large lymphatic collectors were traced. The diameter of lymphatic vessel is crucial for LVA and use of large functioning lymph vessel allows small number of anastomosis for clinical improvements. Recent studies on LVA have shown that lymphatic vessels between 0.3 and 0.6 mm in diameter are used in the surgery &#x0005b;<xref ref-type="bibr" rid="b6-ahm-20-0036">6</xref>&#x0005d;. For example, in the study by Yamamoto et al. &#x0005b;<xref ref-type="bibr" rid="b8-ahm-20-0036">8</xref>&#x0005d;, LVA was successfully performed in a 0.45-mm-diameter lymphatic vessel.</p>
<p>ICG injection can cause side effects, such as anaphylactic reactions, nausea, and fever in less than 1% of patients &#x0005b;<xref ref-type="bibr" rid="b1-ahm-20-0036">1</xref>,<xref ref-type="bibr" rid="b22-ahm-20-0036">22</xref>&#x0005d;. However, no side effects associated were observed with ICG were documented in our study.</p>
</sec>
<sec>
<title>CONCLUSION</title>
<p>The significance of our study was that to the best of our knowledge it was the first to demonstrate and quantify the location of functioning lymphatic vessels in the lower extremities of a healthy Asian population. In our study, the distance between the lymphatic vessel and the landmark was divided by circumference and expressed as a percentage to account for physical differences among the subjects. In this way, it can help surgeons locate incisions in difficult situations.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict"><p>The authors have nothing to disclose.</p></fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-ahm-20-0036">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ogata</surname><given-names>F</given-names></name>
<name><surname>Azuma</surname><given-names>R</given-names></name>
<name><surname>Kikuchi</surname><given-names>M</given-names></name>
<name><surname>Koshima</surname><given-names>I</given-names></name>
<name><surname>Morimoto</surname><given-names>Y</given-names></name>
</person-group>
<article-title>Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling</article-title>
<source>Ann Plast Surg</source>
<year>2007</year>
<volume>58</volume>
<fpage>652</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b2-ahm-20-0036">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Warren</surname><given-names>AG</given-names></name>
<name><surname>Brorson</surname><given-names>H</given-names></name>
<name><surname>Borud</surname><given-names>LJ</given-names></name>
<name><surname>Slavin</surname><given-names>SA</given-names></name>
</person-group>
<article-title>Lymphedema: a comprehensive review</article-title>
<source>Ann Plast Surg</source>
<year>2007</year>
<volume>59</volume>
<fpage>464</fpage>
<lpage>72</lpage>
</element-citation></ref>
<ref id="b3-ahm-20-0036">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kinmonth</surname><given-names>JB</given-names></name>
<name><surname>Taylor</surname><given-names>GW</given-names></name>
</person-group>
<article-title>The lymphatic circulation in lymphedema</article-title>
<source>Ann Surg</source>
<year>1954</year>
<volume>139</volume>
<fpage>129</fpage>
<lpage>36</lpage>
</element-citation></ref>
<ref id="b4-ahm-20-0036">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Narushima</surname><given-names>M</given-names></name>
<name><surname>Kikuchi</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>Lambda-shaped anastomosis with intravascular stenting method for safe and effective lymphaticovenular anastomosis</article-title>
<source>Plast Reconstr Surg</source>
<year>2011</year>
<volume>127</volume>
<fpage>1987</fpage>
<lpage>92</lpage>
</element-citation></ref>
<ref id="b5-ahm-20-0036">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Campisi</surname><given-names>C</given-names></name>
<name><surname>Boccardo</surname><given-names>F</given-names></name>
</person-group>
<article-title>Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery</article-title>
<source>World J Surg</source>
<year>2004</year>
<volume>28</volume>
<fpage>609</fpage>
<lpage>13</lpage>
</element-citation></ref>
<ref id="b6-ahm-20-0036">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Koshima</surname><given-names>I</given-names></name>
<name><surname>Inagawa</surname><given-names>K</given-names></name>
<name><surname>Urushibara</surname><given-names>K</given-names></name>
<name><surname>Moriguchi</surname><given-names>T</given-names></name>
</person-group>
<article-title>Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities</article-title>
<source>J Reconstr Microsurg</source>
<year>2000</year>
<volume>16</volume>
<fpage>437</fpage>
<lpage>42</lpage>
</element-citation></ref>
<ref id="b7-ahm-20-0036">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Koshima</surname><given-names>I</given-names></name>
<name><surname>Nanba</surname><given-names>Y</given-names></name>
<name><surname>Tsutsui</surname><given-names>T</given-names></name>
<name><surname>Takahashi</surname><given-names>Y</given-names></name>
<name><surname>Itoh</surname><given-names>S</given-names></name>
</person-group>
<article-title>Long-term follow-up after lymphaticovenular anastomosis for lymphedema in the leg</article-title>
<source>J Reconstr Microsurg</source>
<year>2003</year>
<volume>19</volume>
<fpage>209</fpage>
<lpage>15</lpage>
</element-citation></ref>
<ref id="b8-ahm-20-0036">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Narushima</surname><given-names>M</given-names></name>
<name><surname>Yoshimatsu</surname><given-names>H</given-names></name>
<etal/>
</person-group>
<article-title>Minimally invasive lymphatic supermicrosurgery (MILS): indocyanine green lymphography-guided simultaneous multisite lymphaticovenular anastomoses via millimeter skin incisions</article-title>
<source>Ann Plast Surg</source>
<year>2014</year>
<volume>72</volume>
<fpage>67</fpage>
<lpage>70</lpage>
</element-citation></ref>
<ref id="b9-ahm-20-0036">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Koshima</surname><given-names>I</given-names></name>
<name><surname>Yoshimatsu</surname><given-names>H</given-names></name>
<name><surname>Narushima</surname><given-names>M</given-names></name>
<name><surname>Miahara</surname><given-names>M</given-names></name>
<name><surname>Iida</surname><given-names>T</given-names></name>
</person-group>
<article-title>Simultaneous multi-site lymphaticovenular anastomoses for primary lower extremity and genital lymphoedema complicated with severe lymphorrhea</article-title>
<source>J Plast Reconstr Aesthet Surg</source>
<year>2011</year>
<volume>64</volume>
<fpage>812</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b10-ahm-20-0036">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ogata</surname><given-names>F</given-names></name>
<name><surname>Narushima</surname><given-names>M</given-names></name>
<name><surname>Mihara</surname><given-names>M</given-names></name>
<name><surname>Azuma</surname><given-names>R</given-names></name>
<name><surname>Morimoto</surname><given-names>Y</given-names></name>
<name><surname>Koshima</surname><given-names>I</given-names></name>
</person-group>
<article-title>Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema</article-title>
<source>Ann Plast Surg</source>
<year>2007</year>
<volume>59</volume>
<fpage>180</fpage>
<lpage>4</lpage>
</element-citation></ref>
<ref id="b11-ahm-20-0036">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Matsuda</surname><given-names>N</given-names></name>
<name><surname>Doi</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema</article-title>
<source>Plast Reconstr Surg</source>
<year>2011</year>
<volume>128</volume>
<fpage>314e</fpage>
<lpage>321e</lpage>
</element-citation></ref>
<ref id="b12-ahm-20-0036">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Narushima</surname><given-names>M</given-names></name>
<name><surname>Doi</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns</article-title>
<source>Plast Reconstr Surg</source>
<year>2011</year>
<volume>127</volume>
<fpage>1979</fpage>
<lpage>86</lpage>
</element-citation></ref>
<ref id="b13-ahm-20-0036">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Yamamoto</surname><given-names>N</given-names></name>
<name><surname>Doi</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns</article-title>
<source>Plast Reconstr Surg</source>
<year>2011</year>
<volume>128</volume>
<fpage>941</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b14-ahm-20-0036">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Unno</surname><given-names>N</given-names></name>
<name><surname>Nishiyama</surname><given-names>M</given-names></name>
<name><surname>Suzuki</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography</article-title>
<source>Eur J Vasc Endovasc Surg</source>
<year>2008</year>
<volume>36</volume>
<fpage>230</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b15-ahm-20-0036">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Seki</surname><given-names>Y</given-names></name>
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Yoshimatsu</surname><given-names>H</given-names></name>
<etal/>
</person-group>
<article-title>The superior-edge-of-the-knee incision method in lymphaticovenular anastomosis for lower extremity lymphedema</article-title>
<source>Plast Reconstr Surg</source>
<year>2015</year>
<volume>136</volume>
<fpage>665e</fpage>
<lpage>675e</lpage>
</element-citation></ref>
<ref id="b16-ahm-20-0036">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Amore</surname><given-names>M</given-names></name>
<name><surname>Tapia</surname><given-names>L</given-names></name>
<name><surname>Mercado</surname><given-names>D</given-names></name>
<name><surname>Pattarone</surname><given-names>G</given-names></name>
<name><surname>Ciucci</surname><given-names>J</given-names></name>
</person-group>
<article-title>Lymphedema: a general outline of its anatomical base</article-title>
<source>J Reconstr Microsurg</source>
<year>2016</year>
<volume>32</volume>
<fpage>2</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b17-ahm-20-0036">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shah</surname><given-names>C</given-names></name>
<name><surname>Vicini</surname><given-names>FA</given-names></name>
</person-group>
<article-title>Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies</article-title>
<source>Int J Radiat Oncol Biol Phys</source>
<year>2011</year>
<volume>81</volume>
<fpage>907</fpage>
<lpage>14</lpage>
</element-citation></ref>
<ref id="b18-ahm-20-0036">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tomczak</surname><given-names>H</given-names></name>
<name><surname>Nyka</surname><given-names>W</given-names></name>
<name><surname>Lass</surname><given-names>P</given-names></name>
</person-group>
<article-title>Lymphoedema: lymphoscintigraphy versus other diagnostic techniques: a clinician&#x02019;s point of view</article-title>
<source>Nucl Med Rev Cent East Eur</source>
<year>2005</year>
<volume>8</volume>
<fpage>37</fpage>
<lpage>43</lpage>
</element-citation></ref>
<ref id="b19-ahm-20-0036">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Unno</surname><given-names>N</given-names></name>
<name><surname>Inuzuka</surname><given-names>K</given-names></name>
<name><surname>Suzuki</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema</article-title>
<source>J Vasc Surg</source>
<year>2007</year>
<volume>45</volume>
<fpage>1016</fpage>
<lpage>21</lpage>
</element-citation></ref>
<ref id="b20-ahm-20-0036">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Unno</surname><given-names>N</given-names></name>
<name><surname>Nishiyama</surname><given-names>M</given-names></name>
<name><surname>Suzuki</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>A novel method of measuring human lymphatic pumping using indocyanine green fluorescence lymphography</article-title>
<source>J Vasc Surg</source>
<year>2010</year>
<volume>52</volume>
<fpage>946</fpage>
<lpage>52</lpage>
</element-citation></ref>
<ref id="b21-ahm-20-0036">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Szuba</surname><given-names>A</given-names></name>
<name><surname>Rockson</surname><given-names>SG</given-names></name>
</person-group>
<article-title>Lymphedema: classification, diagnosis and therapy</article-title>
<source>Vasc Med</source>
<year>1998</year>
<volume>3</volume>
<fpage>145</fpage>
<lpage>56</lpage>
</element-citation></ref>
<ref id="b22-ahm-20-0036">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hope-Ross</surname><given-names>M</given-names></name>
<name><surname>Yannuzzi</surname><given-names>LA</given-names></name>
<name><surname>Gragoudas</surname><given-names>ES</given-names></name>
<etal/>
</person-group>
<article-title>Adverse reactions due to indocyanine green</article-title>
<source>Ophthalmology</source>
<year>1994</year>
<volume>101</volume>
<fpage>529</fpage>
<lpage>33</lpage>
</element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-ahm-20-0036" position="float">
<label>Fig. 1.</label><caption><p>A real-time indocyanine green (ICG) fluorescence image. An ICG fluorescence image was taken with a near-infrared camera four hours after injection of ICG dye. Lower extremity lymphatic flow can be clearly detected. The arrow indicates the knee.</p></caption>
<graphic xlink:href="ahm-20-0036f1.tif"/></fig>
<fig id="f2-ahm-20-0036" position="float">
<label>Fig. 2.</label><caption><p>Lymphatic vessels are marked on the body. Each small ‘×’ represents a landmark, and the purple line indicates lymphatic vessels detected with a near-infrared camera.</p></caption>
<graphic xlink:href="ahm-20-0036f2.tif"/></fig>
<fig id="f3-ahm-20-0036" position="float">
<label>Fig. 3.</label><caption><p>An illustration of the landmarks. A straight line connecting the points that were drawn and divided into four equal lengths.</p></caption>
<graphic xlink:href="ahm-20-0036f3.tif"/></fig>
<fig id="f4-ahm-20-0036" position="float">
<label>Fig. 4.</label><caption><p>Lymphatic vessel courses in healthy volunteers. The distance between the connecting line and the marked lymphatic vessels was measured. In addition, the distance from each landmark to the lymphatic vessel (mean±standard deviation) was divided by the circumference and calculated as a percentage. Positive values mean anterolateral position of lymphatic vessels relative to landmarks. Negative values mean posteromedial position of lymphatic vessels.</p></caption>
<graphic xlink:href="ahm-20-0036f4.tif"/></fig>
<table-wrap id="t1-ahm-20-0036" position="float">
<label>Table 1.</label>
<caption><p>Characteristics of 30 participants with healthy lower extremities</p></caption>
<table rules="groups" frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Characteristic</th>
<th valign="middle" align="center">Mean&#x000A0;&#x000B1;SD (range)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (yr) </td>
<td valign="top" align="center">29.0&#x000B1;6.4 (24&#x02013;46)</td>
</tr>
<tr>
<td valign="top" align="left">Height (cm) </td>
<td valign="top" align="center">173.7&#x000B1;7.2 (158&#x02013;188)</td>
</tr>
<tr>
<td valign="top" align="left">Weight (kg)</td>
<td valign="top" align="center">70.1&#x000B1;8.7 (56&#x02013;84)</td>
</tr>
<tr>
<td valign="top" align="left">Body mass index (kg/m<sup>2</sup>)</td>
<td valign="top" align="center">23.2&#x000B1;1.9 (20.4&#x02013;27.1)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-ahm-20-0036"><p>SD, standard deviation.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t2-ahm-20-0036" position="float">
<label>Table 2.</label>
<caption><p>Course of lymphatic vessels in healthy volunteers</p></caption>
<table rules="groups" frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Landmark</th>
<th valign="middle" align="center">Mean distance (mm)</th>
<th valign="middle" align="center">Relative distance (%)<sup><xref rid="tfn3-ahm-20-0036" ref-type="table-fn">a)</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Groin femoral artery (A)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;3/4 point between A and B</td>
<td valign="top" align="center">&#x02013;25.5&#x000B1;19.2</td>
<td valign="top" align="center">&#x02013;4.7&#x000B1;3.3</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;2/4 point between A and B</td>
<td valign="top" align="center">&#x02013;45.2&#x000B1;24.6</td>
<td valign="top" align="center">&#x02013;9.0&#x000B1;4.7</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;1/4 point between A and B</td>
<td valign="top" align="center">&#x02013;58.0&#x000B1;32.8</td>
<td valign="top" align="center">&#x02013;13.2&#x000B1;7.2</td>
</tr>
<tr>
<td valign="top" align="left">Medial border of patella (B)</td>
<td valign="top" align="center">&#x02013;53.7&#x000B1;35.7</td>
<td valign="top" align="center">&#x02013;14.6&#x000B1;9.2</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;3/4 point between B and C</td>
<td valign="top" align="center">&#x02013;22.9&#x000B1;24.2</td>
<td valign="top" align="center">&#x02013;6.5&#x000B1;6.8</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;2/4 point between B and C</td>
<td valign="top" align="center">&#x02013;10.2&#x000B1;28.3</td>
<td valign="top" align="center">&#x02013;2.9&#x000B1;7.9</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;1/4 point between B and C</td>
<td valign="top" align="center">10.7&#x000B1;18.2</td>
<td valign="top" align="center">4.4&#x000B1;7.5</td>
</tr>
<tr>
<td valign="top" align="left">Medial malleolus (C)</td>
<td valign="top" align="center">26.2&#x000B1;18.0</td>
<td valign="top" align="center">11.0&#x000B1;7.9</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-ahm-20-0036"><p>Values are presented as mean±standard deviation.</p><p>Positive values mean anterolateral position of lymphatic vessels relative to landmarks. Negative values mean posteromedial position of lymphatic vessels.</p></fn>
<fn id="tfn3-ahm-20-0036"><label>a)</label><p>Distance/circumference.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>